Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Downgrades James Fisher & Sons Plc. (FSJ:LN) to Hold
-
Canaccord Genuity Upgrades Blackline Safety Corp (BLN:CN) (BLKLF) to Buy
-
Arrow Announces Grant of Stock Options
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 10 09 2024] - (CGWL)
-
Engine Capital Sends Letter to Dye & Durham’s Board of Directors Regarding its Concerns About the Company’s Rising and Excessive Leverage
-
Bioceres Crop Solutions (BIOX) PT Lowered to $12.50 at Canaccord Genuity
-
Adicet Bio Inc. (ACET) PT Lowered to $8 at Canaccord Genuity
-
DoubleVerify (DV) PT Lowered to $36 at Canaccord Genuity
-
HIVE Digital Technologies (HIVE) Provides Updated August 2024 Bitcoin HODL Value, ATM Equity Program Details
-
RETRANSMISSION: HIVE Digital Technologies Provides Updated August 2024 Bitcoin HODL Value and ATM Equity Program Details
-
HIVE Digital Technologies Provides Updated August 2024 Bitcoin HODL Value and ATM Equity Program Details
-
G2 Capital Advisors Strengthens Leadership Welcoming Three Industry Veterans as Managing Directors
-
MindgruveMacarta Merges with Icon Commerce
-
Health Union Announces Acquisition of HCP Data & Digital Engagement Company, Adfire Health
-
PharmaForceIQ Announces Majority Investment by Eir Partners to Support and Accelerate Growth
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 09 09 2024] - (CGWL)
-
Eir Partners Announces Majority Growth Investment in PharmaForceIQ
-
Canaccord Genuity Reiterates Buy Rating on Natera (NTRA)
-
Canaccord Genuity Reiterates Buy Rating on Holley (HLLY)
-
Zimmer Biomet (ZBH) PT Lowered to $115 at Canaccord Genuity
-
Travere Therapeutics (TVTX) PT Raised to $23 at Canaccord Genuity
-
Canaccord Genuity Resumes Spire Global (SPIR) at Buy
-
Canaccord Genuity Downgrades ImpediMed (IPD:AU) (IPDQF) to Spec. Buy
-
Canaccord Genuity Reiterates Hold Rating on Yeti Holdings Inc. (YETI)
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 06 09 2024] - (CGWL)
-
Andrea Bozzi, Charles Andrez and Charles-Henri Filippi Join Evercore’s Paris Office
-
CVW CleanTech Announces Closing of Private Placement Totalling $16.75 Million
-
Canaccord Genuity Reiterates Buy Rating on SharkNinja (SN)
-
Canaccord Genuity Reiterates Buy Rating on Bowlero Corp. (BOWL)
-
Traeger Inc. (COOK) PT Raised to $6 at Canaccord Genuity
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 05 09 2024] - (CGWL)
-
Canaccord Genuity Reiterates Buy Rating on Braze Inc (BRZE)
-
Smartsheet Inc. (SMAR) PT Raised to $60 at Canaccord Genuity
-
FuelCell Energy (FCEL) PT Lowered to $1.25 at Canaccord Genuity
-
Zeta Global Holdings Corp (ZETA) PT Raised to $30 at Canaccord Genuity
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 04 09 2024] - (CGWL)
-
Canaccord Genuity Reiterates Buy Rating on Phreesia Inc. (PHR)
-
c3.ai (AI) PT Lowered to $23 at Canaccord Genuity
-
Zeta Global (ZETA) Prices 13.2M Share Offering at $23.50/sh
-
Thor Explorations Announces Exploration Update on the Douta Gold Project, Senegal
-
Zeta Announces Pricing of Public Offering of Class A Common Stock
-
EPAM Systems (EPAM) to Acquire NEORIS
-
EPAM Announces Agreement to Acquire NEORIS
-
Canaccord Genuity Reiterates Buy Rating on GitLab Inc (GTLB)
-
Form 8.3 - [ECKOH PLC - 03 09 2024] - (CGWL)
-
Canaccord Genuity Reiterates Buy Rating on 10X Genomics (TXG)
-
Canaccord Genuity Reiterates Buy Rating on Arcturus Therapeutics (ARCT)
-
PagerDuty (PD) PT Lowered to $24 at Canaccord Genuity
-
Canaccord Genuity Starts West African Resources Ltd (WAF:AU) at Buy
-
SinglePoint Inc. Provides Overview of Round Up Quantity Report from DTCC Detailing the Distribution of Common Stock to Shareholders of Record as of August 15, 2024, to Preserve Round Lot Shareholders
